Company / Cost of Revenue
Becton Dickinson Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$11.9B
FY2025
5-year range
$10.4B / $11.9B
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
#10 of 113
Health Care
What the data says
Among 113 Health Care companies, Becton Dickinson is in the bottom 9% for cost of revenue. Cost of Revenue has fluctuated over the past 10 years, ranging from $6.1B in FY2017 to $11.9B in FY2025.
Based on SEC 10-K filings.
$11.9B in FY2025 with a 5-year CAGR of +5.1%. Top quartile in the Health Care sector.
Increased from $11.2B to $11.9B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 113This company $11.9B Sector average $11.3B
▼
+5.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 7.8% year-over-year.
- Ranks #10 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.9B | +7.8% |
| FY2024 | $11.1B | -1.3% |
| FY2023 | $11.2B | +7.8% |
| FY2022 | $10.4B | -1.0% |
| FY2021 | $10.5B | +13.2% |
| FY2020 | $9.3B | +3.0% |
| FY2019 | $9.0B | +3.3% |
| FY2018 | $8.7B | +42.2% |
| FY2017 | $6.1B | -5.6% |
| FY2016 | $6.5B | +16.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026